Back to Trades
Haviland Kate
DirectorCIK 0001663022
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 4
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 3
- Active
- 2025–2026
Haviland Kate, Director, has filed 4 SEC reports (2025–2026), spread across 3 companies, totaling $33.8M in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
4 loaded
| Jun 10 | BCAX Bicara Therapeutics Inc. | Haviland Kate | Director | Award | $400.4K |
| May 1 | AVLN Avalyn Pharma Inc. | Haviland Kate | Insider | Award | $485.6K |
| Apr 29 | AVLN Avalyn Pharma Inc. | Haviland Kate | Insider | Other | $0 |
| Jul 21 | BPMC Blueprint Medicines Corp | Haviland Kate | Chief Executive Officer, Director | Grant | $32.9M |
4 filings